Jason Fontenot BS, MS, PhD

Jason Fontenot, Ph.D., is a Principal Scientist and group leader in Immunology Research at Biogen Idec, in Cambridge, Massachusetts. His lab’s research is focused on understanding pathways governing the differentiation and function of helper T lymphocytes and their role in immunity and tolerance. In additional to his discovery research work, Dr Fontenot is research lead for the Daclizumab (anti-cd25) development program in relapsing-remitting multiple sclerosis.

Dr Fontenot received his PhD in immunology from the University of Washington in Seattle, WA and postdoctoral training at Rockefeller University in New York City, NY. As a graduate student, while working in the laboratory of Alexander Rudensky, Dr Fontenot identified the transcription factor Foxp3 as an essential determinant of regulatory T cell development and function.